Cimetidine and omeprazole do not affect cyclosporine disposition by the rat liver
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Cyclosporine has been used with increased frequency, occasionally in conjunction with cimetidine and omeprazole. The present study was undertaken to study a possible interaction between either of the two drugs and cyclosporine in the liver. The isolated perfused rat liver was used with recirculation of perfusate for 150 min. 6 experiments were performed with each of the following: cyclosporine alone, cyclosporine with cimetidine, and cyclosporine with omeprazole. Initial concentrations of cyclosporine, cimetidine and omeprazole were 600 μg/ml, 12.5 μg/ml, and 4.5 μg/ml, respectively. At 1 and 2 h of perfusion 1 μg of omeprazole was added to perfusate. Cyclosporine concentration was determined at 30 min intervals. Results at 150 min expressed as percentage of the initial concentration of cyclosporine were 59±3%, 55±6%, and 60±9% for cyclosporine alone, with cimetidine and with omeprazole, respectively. The elimination rate of cyclosporine by the liver did not change during the entire experiment with the addition of cimetidine or omeprazole. Thus, it is concluded that short administration of cimetidine or omeprazole will not affect cyclosporine metabolism by the liver.
- Jarrell B.E., Moritz M.J., Radomski J. (1988): Cyclosporine. In: Maddney W.C. ed. Transplantation of the liver. Elsevier, New York, pp. 249–278.
- Bereridge T., Cyclosporine A. (1982): In: White D.J.G. ed, Oxford, Elsevier Biomedical Press, p. 35.
- Ahonen J., Paimela H., Kauste A., Hayry P., Eklund B., Pettersson E. (1983): Rainitidine and cimetidine in renal transplantation: A clinical trial. Int. J. Tissue React., 5, 373–378.
- Sheets J.S., Mason J.I. (1984): Ketoconazole: A potent inhibitor of cytochrome P-450 dependent drug metabolism in rat liver. Drug Metab. Dispos., 12, 603–606.
- Rodrigues A.D., Gibson G.G., Ioannides C., Parke D.V. (1987): Interactions of imidazole antifungal agents with purified cytochrome P-450 proteins. Biochem. Pharmacol., 36, 4277–4281. CrossRef
- Ritter J.K., Franklin M.R. (1987): Induction and inhibition of rat hepatic drug metabolism by N-substituted imidazole drugs. Drug Metab. Dispos., 15, 335–343.
- Venkataramanan R., Burckart G.J., Ptachinski R. (1985): Pharmacokinetics and monitoring of cyclosporine following orthotopic liver transplantation. Semin. Liver Dis., 5, 357–368. CrossRef
- Burckart G.J., Starzl T.E., Venkataramanan H., et al. (1986): Excretion of cyclosporine and its metabolites in human bile. Transplant Proc., 18, 46–49.
- Smogyi A., Gugler R. (1982): Drug interactions with cimetidine. Clin. Pharmacokinet., 7, 23–41. CrossRef
- Diaz D., Fabre I., Daujat M., et al. (1990): Omeprazole is an aryl-hydrocarbon-like inducer of human hepatic cytochrome P-450. Gastroenterology, 99, 737–747.
- Farrell G.C., Murray M. (1990): Human cytochrome P-450 isoforms. Gastroenterology, 99, 885–889.
- Bruck R., Krepel Z., Melzer E., Bar-Meir S. (1988): The effect of PGE2 on hepatic blood flow and bile indocyanine green in the rat. Prostaglandins, 37, 531–538. CrossRef
- Gores G.J., Kost L.J., LaRusso N.F. (1986): The isolated perfused rat liver, conceptual and practical considerations. Hepatology, 6, 511–517. CrossRef
- Gugler R., Jensen J.C. (1985): Omeprazole inhibits oxidative drug metabolism. Studies with diazepam and phenytoin in vivo and 7-ethoxycoumarin in vitro. Gastroenterology, 89, 1235–1241.
- Jensen J.C., Gugler R. (1986): Inhibition of human liver cytochrome P-450 by omeprazole. Br. J. Clin. Pharmacol., 21, 328–330.
- Chenery R.J., Ayrton A., Oldham H.G., Norman S.J., Standring P. (1988): The interaction of omeprazole with rat liver cytochrome P-450 mediated monooxygenase reactions in vitro and in vivo. Biochem. Pharmacol., 37, 1407–1414. CrossRef
- Parkinson A., Hurwitz A. (1991): Omeprazole and the induction of human cytochrome P-450: A response to concerns about potential adverse effects. (Correspondence). Gastroenterology, 100, 1157–1164.
- Andersson T., Cederberg C., Edvardsson G., Heggelund A., Lundbord P. (1990): Effect of omeprazole treatment on diazepam plasma levels in slow versus normal rapid metabolisers of omeprazole. Clin. Pharmacol. Ther., 47, 79–85. CrossRef
- Andersson T., Regardh C.G., Dahl-Puustinen M.I., Bertilsson L. (1989): Slow omeprazole metabolizers are also poor S-mephenytoin hydroxylators. Ther. Drug. Monit., 12, 415–416. CrossRef
- Shimada T., Misone K.S., Guengerich F.P. (1986): Human liver microsomal cytochrome P-450 mephenytoin 4-hydroxylase a prototype of genetic polymorphism in oxidative drug metabolism: purification and characterization of two similar forms involved in the reaction. J. Biol. Chem., 261, 909–921.
- Lucey M.R., Kolars J.C., Merion R.M., Campbell D.A., Aldrich M., Watkins P.B. (1990): Cyclosporine toxicity at therapeutic blood levels and cytochrome P-450IIIA. Lancet, 335, 11–15. CrossRef
- Jarowenko M.V., Van Buren C.T., Kramer W.G. (1986): Ramitidine, cimetidine and the cyclosporine-treated recipient. Transplantation, 42, 311–312. CrossRef
- Pachon J., Lorber M.I., Bia M.J. (1989): Effects of H2-receptor antagonists on renal function in cyclosporine treated renal transplant patients. Transplantation, 47, 254–259. CrossRef
- Castelao A.M., Sabate I., Grino J.M., et al. (1988): Cyclosporine-drug interactions. Transplant Proc., 20, 66–69.
- D’Souza M.J., Pollock S.H., Solomon H.M. (1988): Cyclosporine-cimetidine interaction. Drug Metab. Dispos., 16, 57–59.
- Puff M.R., Carey W.D., Pippenger C.E., Vogt D.P. (1989): Cimetidine alters cyclosporine A metabolism in liver transplantation patients. Gastroenterology, 9, A647.
- Cimetidine and omeprazole do not affect cyclosporine disposition by the rat liver
European Journal of Drug Metabolism and Pharmacokinetics
Volume 18, Issue 4 , pp 355-358
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- rat liver
- Industry Sectors
- Author Affiliations
- 1. Department of Gastroenterology, Sheba Medical Center, 52621, Tel Hashomer, Israel
- 2. Pharmacology Unit, Beilinson Hospital, Petah Tiqua, Israel
- 3. Sackler School of Medicine, Tel Aviv, Israel